CD19 and lymphoma: Teipel Teipel R R Kroschinsky Kroschinsky F F Kramer Kramer M M Prevalence and variation of CHIP in patients with aggressive lymphomas undergoing CD19-directed CAR T-cell treatment Prevalence and variation of CHIP in patients with aggressive lymphomas undergoing CD19-directed CAR T-cell treatment Blood Adv Blood Adv 2022 2022 6 6 1941 1941 1946 1946 10.1182/bloodadvances.2021005747 10.1182/bloodadvances.2021005747 supplied-pmid 35008107?